antimicrobial resistance

CGD’s working group, A New Grand Bargain to Improve the Antimicrobial Market for Human Health, launched in 2022, explores how to improve the market for antimicrobials and increase access, stewardship, and innovation, particularly in low- and middle-income countries.

More from the Series

Blog Post
In the Fight against AMR, We Can Learn from Efforts to Protect the Ozone Layer
Anthony McDonnell
March 13, 2024
When world leaders gather in September for this year’s UN General Assembly, antimicrobial resistance (AMR) will be on the agenda. For people like me who care passionately about this issue, this is a welcome opportunity to address a global problem with a global solution. Ahead of September, we need t...
REPORTS
A New Grand Bargain to Improve the Antimicrobial Market for Human Health
Anthony McDonnell et al.
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
POLICY PAPERS
The Not-So-Invisible Hand of “Stewardship,” Within and Beyond Antibiotics: Implications of Non-Monetary Pharmaceutical Controls for Access to Medicines
Rachel Silverman Bonnifield
and
Katherine Klemperer
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
BRIEFS
Overcoming Barriers to Improve Antimicrobial Access, Innovation, and Stewardship in India
Parshuram Hotkar et al.
July 31, 2023
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to impro...
Blog Post
Pandemic Proof: Learning from Sweden on Superbugs
Javier Guzman
January 26, 2023
Malin Grape, Sweden’s Ambassador of antimicrobial resistance (AMR), joins Javier Guzman to discuss Sweden’s track record on AMR, the outlook and priorities for its EU presidency, and initial reflections on Sweden’s innovative program for purchasing antimicrobials.
Blog Post
Why We Need a New Grand Bargain for How the World Buys Antibiotics
Katherine Klemperer et al.
September 26, 2022
Antimicrobial resistance is a major global problem. Today, drug resistant infections kill an estimated 1.27 million people per year, and low- and middle-income countries bear the brunt of AMR-related deaths and illness. Changing how we buy antimicrobials can help solve the problem.
Blog Post
It’s (Past) Time We Prepare for the Next Pandemic
Rebecca Forman
May 01, 2018
Last week, the Center for Strategic and International Studies (CSIS) hosted an advance screening of the PBS Great Decisions episode, "Global Health: Preventing Pandemic.” After the screening, a panel of American global health experts took to the stage to discuss US leadership in ...